Examples of using Luminity in English and their translations into Hungarian
{-}
- 
                        Medicine
                    
- 
                        Colloquial
                    
- 
                        Official
                    
- 
                        Ecclesiastic
                    
- 
                        Financial
                    
- 
                        Programming
                    
- 
                        Official/political
                    
- 
                        Computer
                    
Luminity Patients.
How to store Luminity.
What Luminity contains?
The European Commission granted amarketing authorisation valid throughout the European Union for Luminity to Bristol-Myers Squibb Pharma Belgium Sprl on 20 September 2006.
Luminity has not been specifically studied in elderly patients.
In two of these studies, Luminity was compared with placebo(a dummy treatment).
Luminity is injected, it travels in the veins to the heart.
During echocardiography, the perflutren microspheres in Luminity reflect ultrasound waves differently from the surrounding tissues.
Luminity is a gas and solvent for dispersion for injection or infusion.
Before activation, Luminity contains a gas, perflutren, and a solution of fatty substances called phospholipids.
Luminity has not been specifically studied in patients with renal impairment.
The naturally occurring phospholipids in Luminity(see section 6.1) are distributed in the endogenous lipid pools in the body(for example, liver) whereas the synthetic component(MPEG5000) has been shown to be excreted in the urine in preclinical studies.
Luminity is an ultrasound contrast agent that contains tiny gas bubbles.
Luminity 150 microlitres/ ml solution for dispersion for injection or infusion.
Luminity 150 microlitres/ml gas and solvent for dispersion for injection/infusion.
Luminity is activated by using the Vialmix which has a programmed shaking time of 45 seconds.
Luminity 150 microlitres/ ml solution for dispersion for injection or infusion Perflutren Intravenous use.
Luminity may be diluted with sodium chloride 9 mg/ml(0.9%) solution for injection or glucose 50 mg/ml(5%) solution for injection.
Luminity is an ultrasound contrast agent that contains microspheres(tiny bubbles) of perflutren gas as the active substance.
Luminity is a solution for dispersion for injection or infusion and is available in a pack containing one or four single-use 1.5 ml vials.
Luminity is a solution for injection or infusion(drip) into a vein that contains microspheres(tiny bubbles) of perflutren gas as the active substance.
Luminity is a solution for injection or infusion(drip into a vein) that contains microspheres(tiny bubbles) of perflutren gas as the active substance.
Luminity was effective in enhancing the image of the left ventricle, and it was more effective than placebo in the studies where Luminity and placebo were compared.
Luminity is given to you before or during your ultrasound examination by healthcare professionals such as doctors who are experienced in this type of examination. They will calculate the right dose for you.
As Luminity consists of microspheres that are stable and small enough for transpulmonary passage, enhanced echo signals in the left heart and systemic circulation are obtained.
Rats treated with Luminity for 1 month exhibited dose-related, reversible perivascular and peribronchiolar eosinophil infiltration, alveolar macrophage accumulation and increased goblet cell size and number in the lungs.
As Luminity has no pharmacologic effect, and on the basis of its pharmacokinetic and pharmacodynamic profiles, no or negligible influence is expected with the use of this product on the ability to drive or use machines.
Luminity is used in adults to obtain a clearer scan of the chambers of the heart, especially of the left ventricle, during echocardiography(a diagnostic test where an image of the heart is obtained using ultrasound).
Luminity should be used only after careful consideration and such use should be monitored closely during administration in patients with adult respiratory distress syndrome, endocarditis, a heart with prosthetic valves, acute states of systemic inflammation or sepsis, known states of hyperactive coagulation and/or recurrent thromboembolism.